Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint Appoints Randy AuCoin to Board of Directors

TheNewsWire December 20, 2021

Ventripoint Receives Additional Funding to Develop Next Generation of the VMS+, Whole-Heart Analysis System

TheNewsWire December 6, 2021

Ventripoint Applauds the US Government for Establishing an Additional Payment to Doctors for Analyzing 3D Heart Scans

TheNewsWire November 29, 2021

Ventripoint Selected by Life Sciences Ontario as 2021 Success Story

TheNewsWire November 24, 2021

Ventripoint Provides Corporate Update on Market Adoption of VMS+ Whole-heart Analysis System

TheNewsWire November 22, 2021

Ventripoint Passes Audit of Manufacturing Facility for Canadian and US Markets

TheNewsWire November 9, 2021

Ventripoint Appoints Fiona Fitzgerald to the Board of Directors

TheNewsWire October 25, 2021

Ventripoint Installs VMS+ 3.0 Unit at East Midlands Congenital Heart Centre

TheNewsWire October 21, 2021

Ventripoint Diagnostics Ltd. Announces Closing of Upsized Bought Deal Offering of Units

TheNewsWire October 20, 2021

Ventripoint Diagnostics Ltd. Announces Filing of Second Amended and Restated MD&A

TheNewsWire October 13, 2021

Ventripoint Diagnostics Ltd. Announces Filing of Amended and Restated Interim Financial Statements and MD&A

TheNewsWire October 1, 2021

Ventripoint Diagnostics Ltd. Announces Upsize to Previously Announced Bought Deal Offering of Units to $7 Millon

TheNewsWire September 28, 2021

IIROC Trading Resumption - VPT

PR Newswire September 28, 2021

Ventripoint Diagnostics Ltd. Announces $5 Million Bought Deal Offering of Units

TheNewsWire September 27, 2021

IIROC Trading Halt - VPT

PR Newswire September 27, 2021

Ventripoint Issues Option Grants to Consultant

TheNewsWire September 17, 2021

Ventripoint Provides Update on Clinical Studies

TheNewsWire September 15, 2021

Ventripoint Provides Update on Growth Initiatives and Sales

TheNewsWire September 14, 2021

Ventripoint Issues Option Grants to Consultants and Reports Options Exercise

TheNewsWire September 7, 2021

Ventripoint Reports Second Quarter 2021 Financial Statements and MD&A

TheNewsWire September 3, 2021